Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by canon12345on Jan 14, 2021 11:32am
292 Views
Post# 32294283

Steps forward and still needed

Steps forward and still neededWhile Dr. Adams has made some strides since the new VMS 3.0 came out there is one major step the company needs to take to propel the stock to much higher levels. We all know that is a substantial Sales order from one of these hospitals ie: MD Anderson or perhaps the Kings College Hospital in London or other top notch facility. Having Chinese interest in the stock also is interesting as this is also the possibility for a large order from China. Dr. Adams also had the foresite to see the market possibilities in the Veterinary space. Far to early to say how this will go but is still a shrewd move and could lead to a secondary or perhaps far larger market then previously thought for the 3.0. The ground work is actually quite impressive in the past few months but we need that large order and several more if this stock is going to go to the heights some of us here believe it will.    

<< Previous
Bullboard Posts
Next >>